Visx Valued At Roughly $1.8 Bil. By Icahn In Takeover Bid
This article was originally published in The Gray Sheet
Executive Summary
Financier Carl Icahn intends to auction LASIK eye surgery system manufacturer Visx for a minimum of $32 per share if he is successful in electing a rival slate of director candidates at the company's upcoming annual shareholder meeting on May 4.